RK STRATEGIES, INC.

Lobbying for ADIAL PHARMACEUTICALS, INC. · Pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $10,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

FDA issues related to Addiction

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem